FIELD: medicine.
SUBSTANCE: invention relates to medicine and medical industry, namely to technology of medicinal agents, and represents antivirus agent in the form of gel, containing human leukocytic interferon, base, preservative nipagin, differing by the fact that it additionally contains physiological solution, and base is represented by chitosan succinate, at a certain ratio of components per 1 ml of mixture.
EFFECT: production of antivirus agent in the form of gel.
Title | Year | Author | Number |
---|---|---|---|
ANTIVIRAL GEL AS GEL BASED ON HUMAN LEUKOCYTE INTERFERON | 2005 |
|
RU2302881C2 |
RECOMBINANT INTERFERON-BASE ANTIVIRAL AGENT AS OINTMENT, SUPPOSITORY, CREAM, LINIMENT | 1999 |
|
RU2150291C1 |
COMPLEX ANTIVIRAL MEDICATION FOR EXTERNAL APPLICATION IN TREATMENT OF HERPES VIRUS INFECTIONS | 2010 |
|
RU2438697C1 |
ALPHA-2-INTERFERON-BASED ANTIVIRAL AGENT IN CREAM FORM | 1998 |
|
RU2159609C2 |
MEDICINAL GEL | 2000 |
|
RU2184564C2 |
ANTIVIRAL AGENT | 2000 |
|
RU2187330C1 |
MEANS FOR NASAL APPLICATION | 2016 |
|
RU2629330C1 |
USE OF LIOPHILISED PREPARATION OF ALLOFIBROBLASTS FOR TREATING HERPES VIRUS DISEASES | 2012 |
|
RU2483739C1 |
ANTIVIRAL AGENT | 2001 |
|
RU2204410C1 |
MEDICINAL PRODUCT BASED ON INTERFERON ALFA-2B HUMAN RECOMBINANT METHIONINE-FREE | 2022 |
|
RU2795854C1 |
Authors
Dates
2010-11-27—Published
2009-05-12—Filed